logo
Plus   Neg
Share
Email

Kite, HiFiBiO Join To Develop Antibodies Against Acute Myeloid Leukemia

Kite, a Gilead Company (GILD), and HiFiBiO Therapeutics have entered into a two-year research collaboration and license agreement in acute myeloid leukemia. HiFiBiO
will use its proprietary technology platforms to identify acute myeloid leukemia targets and anti-AML specific antibodies for Kite's use in cell therapies.

HiFiBiO will receive an upfront payment and will be eligible for additional payments based on the achievement of certain research milestones. Kite will have an exclusive option to opt in on any targets discovered through the collaboration, for which HiFiBiO will receive an additional payment and will be eligible for additional milestone payments, as well as royalty payments.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Orca Bay Foods, LLC recalled about 4,450 pounds of Trader Joe's brand Gluten Free Battered Halibut products for undeclared wheat and milk allergens, according to a statement published by the U.S. Food and Drug Administration (FDA). The action was initiated after it was discovered that product containing Wheat and Milk was distributed in packaging. Lee Kun-hee, the Chairman of South Korean conglomerate Samsung Group, has died on October 25, at the age of 78. It was he who transformed Samsung into a South Korean behemoth, and the world's largest manufacturer of smartphones, televisions, and semiconductors. As per reports, Lee's only son Jae-yong, who currently serves as vice chairman of Samsung Electronics, is likely to take over Samsung. Toy and board game company Hasbro, Inc. (HAS) reported Monday net earnings attributable to Hasbro for the third quarter of $220.90 million or $1.61 per share, compared to pro forma net earnings of $216.5 million or $1.57 per share in the year-ago period. Excluding items, adjusted earnings for the...
Follow RTT